Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects
PHASE1TJ003234RAR101 is a first-in-human (FIH), single-center, randomized, double...
A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis
PHASE2This is a multi center,randomized,double-blind,double-dummy,active-controll...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
PHASE2This is a randomized, double-blind, placebo-controlled, multi-center trial ...
Location
University of Arkansas